Sablik KA - Search Results

1

Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection.

Sablik KA, Clahsen-van Groningen MC, Hesselink DA, van Gelder T, Betjes MGH. Sablik KA, et al. PLoS One. 2018 May 10;13(5):e0196552. doi: 10.1371/journal.pone.0196552. eCollection 2018. PLoS One. 2018. PMID: 29746495 Free PMC article.

2

Chronic-active antibody-mediated rejection with or without donor-specific antibodies has similar histomorphology and clinical outcome - a retrospective study.

Sablik KA, Clahsen-van Groningen MC, Looman CWN, Damman J, Roelen DL, van Agteren M, Betjes MGH. Sablik KA, et al. Transpl Int. 2018 Aug;31(8):900-908. doi: 10.1111/tri.13154. Epub 2018 Apr 16. Transpl Int. 2018. PMID: 29570868 Free article.

3

Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection.

Sablik KA, Clahsen-van Groningen MC, Looman CWN, Damman J, van Agteren M, Betjes MGH. Sablik KA, et al. BMC Nephrol. 2019 Jun 14;20(1):218. doi: 10.1186/s12882-019-1385-z. BMC Nephrol. 2019. PMID: 31200654 Free PMC article.

4

Increased CD16 expression on NK cells is indicative of antibody-dependent cell-mediated cytotoxicity in chronic-active antibody-mediated rejection.

Sablik KA, Litjens NHR, Klepper M, Betjes MGH. Sablik KA, et al. Transpl Immunol. 2019 Jun;54:52-58. doi: 10.1016/j.trim.2019.02.005. Epub 2019 Feb 19. Transpl Immunol. 2019. PMID: 30794946

5

Banff lesions and renal allograft survival in chronic-active antibody mediated rejection.

Sablik KA, Clahsen-van Groningen MC, Damman J, Roelen DL, Betjes MGH. Sablik KA, et al. Transpl Immunol. 2019 Oct;56:101213. doi: 10.1016/j.trim.2019.101213. Epub 2019 Jul 4. Transpl Immunol. 2019. PMID: 31279831

6

Clinical Relevance of Arteriolar C4d Staining in Patients With Chronic-active Antibody-mediated Rejection: A Pilot Study.

Snijders MLH, Sablik KA, van den Bosch TPP, Hesselink DA, Betjes MGH, Batal I, Clahsen-van Groningen MC. Snijders MLH, et al. Among authors: sablik ka. Transplantation. 2020 May;104(5):1085-1094. doi: 10.1097/TP.0000000000002957. Transplantation. 2020. PMID: 31517782

7

Immune Cell Infiltrate in Chronic-Active Antibody-Mediated Rejection.

Sablik KA, Jordanova ES, Pocorni N, Clahsen-van Groningen MC, Betjes MGH. Sablik KA, et al. Front Immunol. 2020 Feb 4;10:3106. doi: 10.3389/fimmu.2019.03106. eCollection 2019. Front Immunol. 2020. PMID: 32117198 Free PMC article.

8

ARHGDIB and AT1R autoantibodies are differentially related to the development and presence of chronic antibody-mediated rejection and fibrosis in kidney allografts.

Betjes MGH, Sablik KA, Litjens NHR, Otten HG, de Weerd AE. Betjes MGH, et al. Among authors: sablik ka. Hum Immunol. 2021 Feb;82(2):89-96. doi: 10.1016/j.humimm.2020.12.003. Epub 2021 Jan 6. Hum Immunol. 2021. PMID: 33358038 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters